Design Therapeutics Inc.
DSGN | NASDAQ
$12.81
+$0.26 (+2.07%)
Sep 22, 2026, 10:47 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -7.69 | -7.01 | -2.23 | -9 | -27.81 | -138.30 |
PEG Ratio | -0.20 | 0.27 | -0.51 | -0.19 | -0.18 | -0.46 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.53 | 1.44 | 0.53 | 1.75 | 2.57 | -99.70 |
P/FCF Ratio | -9.86 | -8.04 | -2.52 | -10.94 | -31.82 | -129 |
P/OCF Ratio | -9.89 | -8.10 | -2.53 | -11.14 | -33.48 | -130.13 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | n/a |
Quick Ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 | 15.55 |
Current Ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 | 15.55 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -32.84% | -20.48% | -24.08% | -19.34% | -9.30% | 73.18% |
Return on Assets | -30.85% | -19.67% | -23.08% | -18.56% | -9.10% | -22.68% |
Return on Invested Capital | -37.13% | -25.52% | -27.85% | -20.42% | -9.29% | -25.03% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DSGN